| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Associations of HDL subclasses and lipid content with complement proteins over the menopause transition: The SWAN HDL ancillary study
|
El Khoudary, Samar R.
|
|
|
16 |
5 |
p. 649-657
|
article
|
| 2 |
Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort
|
Zhu, Yinjie
|
|
|
16 |
5 |
p. 658-666
|
article
|
| 3 |
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia
|
Gaudet, Daniel
|
|
|
16 |
5 |
p. 676-684
|
article
|
| 4 |
Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio
|
Manubolu, Venkat S.
|
|
|
16 |
5 |
p. 715-724
|
article
|
| 5 |
Corrigendum to Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association [Journal of Clinical Lipidology Volume 13, Issue 3, May–June 2019, Pages 374-392]
|
Wilson, Don P.
|
|
|
16 |
5 |
p. 759
|
article
|
| 6 |
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States
|
Spencer, Scott J.
|
|
|
16 |
5 |
p. 667-675
|
article
|
| 7 |
Editorial Board
|
|
|
|
16 |
5 |
p. i-iii
|
article
|
| 8 |
Effectiveness of medical nutrition therapy in the management of adult dyslipidemia: A systematic review and meta-analysis
|
Mohr, Alex E.
|
|
|
16 |
5 |
p. 547-561
|
article
|
| 9 |
Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia
|
Karwatowska-Prokopczuk, Ewa
|
|
|
16 |
5 |
p. 617-625
|
article
|
| 10 |
Efficacy and safety of self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester (MND-2119) versus highly purified eicosapentaenoic acid ethyl ester in patients with hypertriglyceridemia: Results from a 12-week randomized, double-blind, active-controlled, phase 3 study
|
Mori, Takuya
|
|
|
16 |
5 |
p. 704-714
|
article
|
| 11 |
Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations
|
Vigna, Giovanni B.
|
|
|
16 |
5 |
p. 591-595
|
article
|
| 12 |
Familial hypobetalipoproteinemia caused by homozygous loss-of-function mutations in PCSK9: A case report
|
Kudo, Takanori
|
|
|
16 |
5 |
p. 596-600
|
article
|
| 13 |
From the editor: Lipidology resurgent as the pandemic wanes
|
Guyton, John R.
|
|
|
16 |
5 |
p. 545
|
article
|
| 14 |
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis
|
Zhang, Guofu
|
|
|
16 |
5 |
p. 626-634
|
article
|
| 15 |
High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey
|
Farnier, Michel
|
|
|
16 |
5 |
p. 685-693
|
article
|
| 16 |
Impact of a virtual lipid clinic on lipid-lowering therapy, LDL cholesterol levels, and outcomes in patients with acute coronary syndrome
|
García, Rafael Vázquez
|
|
|
16 |
5 |
p. 635-642
|
article
|
| 17 |
Impact of small dense low-density lipoprotein cholesterol and triglyceride-rich lipoproteins on plaque rupture with ST-segment elevation myocardial infarction
|
Arai, Taito
|
|
|
16 |
5 |
p. 725-732
|
article
|
| 18 |
Impact of the COVID-19 pandemic on cardiometabolic health parameters in children with preexisting dyslipidemia
|
Schefelker, Juliette
|
|
|
16 |
5 |
p. 643-648
|
article
|
| 19 |
Long-term safety and efficacy of MND-2119 (self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester) in patients with hypertriglyceridemia: Results from a multicenter, 52-week, open-label study
|
Mori, Takuya
|
|
|
16 |
5 |
p. 737-746
|
article
|
| 20 |
Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten
|
Vuorio, Alpo
|
|
|
16 |
5 |
p. 757-758
|
article
|
| 21 |
News from NLA
|
|
|
|
16 |
5 |
p. 546
|
article
|
| 22 |
Novel APOB nonsense variant related to familial hypobetalipoproteinemia and hepatic steatosis: A case report and review
|
Rodríguez de Vera-Gómez, Pablo
|
|
|
16 |
5 |
p. 601-607
|
article
|
| 23 |
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome
|
Atallah, Isis
|
|
|
16 |
5 |
p. 583-590
|
article
|
| 24 |
Plasma HDL pattern, cholesterol efflux and cholesterol loading capacity of serum in carriers of a novel missense variant (Gly176Trp) of endothelial lipase
|
Pisciotta, Livia
|
|
|
16 |
5 |
p. 694-703
|
article
|
| 25 |
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients
|
Pérez de Isla, Leopoldo
|
|
|
16 |
5 |
p. 733-736
|
article
|
| 26 |
Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review
|
Masson, Walter
|
|
|
16 |
5 |
p. 562-573
|
article
|
| 27 |
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes
|
Moriarty, Patrick M.
|
|
|
16 |
5 |
p. 747-756
|
article
|
| 28 |
Small interfering ribonucleic acid for cholesterol lowering – Inclisiran
|
Soffer, Daniel
|
|
|
16 |
5 |
p. 574-582
|
article
|
| 29 |
Table of Contents
|
|
|
|
16 |
5 |
p. iv-vi
|
article
|
| 30 |
Under-reporting and under-representation of non-Hispanic Black subjects in lipid-lowering atherosclerotic cardiovascular disease outcomes trials: A systematic review
|
Grant, Jelani K.
|
|
|
16 |
5 |
p. 608-616
|
article
|
| 31 |
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
|
Wilson, Don P.
|
|
|
16 |
5 |
p. e77-e95
|
article
|
Journal description